Remedent, Inc. Reports Earnings Results for the Second Quarter Ended September 30, 2019
November 15, 2019 at 03:29 am IST
Share
Remedent, Inc. announced earnings results for the second quarter ended September 30, 2019. For the second quarter, the company announced sales was USD 242,070 compared to USD 345,640 a year ago. Operating loss was USD 96,526 compared to USD 112,643 a year ago. Net loss was USD 159,591 compared to USD 76,152 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to Basic EPS - Continuing Operations of USD 0 a year ago. For the half year, sales was USD 552,034 compared to USD 780,488 a year ago. Operating loss was USD 163,698 compared to USD 269,230 a year ago. Net loss was USD 350,736 compared to USD 234,916 a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.01 a year ago.
Remedent, Inc. specializes in the research, development and manufacturing of oral care and cosmetic dentistry products. The Company designs, develops, manufactures and distributes its cosmetic dentistry products, including a full line of professional dental products that are distributed in Europe, Asia, Middle East and the United States. The Company's operating segment consists of dental products and oral hygiene products sold by Remedent Inc., Remedent N.V., and Biotech Dental Benelux N.V. The Company offers over-the-counter (OTC) tooth whitening products. It has three primary products: River 8, a prefabricated veneer; its custom-made GlamSmile Veneers and the SmileMe mirror. The Company has developed a range of prefabricated, ready-to-use veneers that the Company has branded as River8. The Company's product in the professional oral care and cosmetic dentistry is the GlamSmile veneer. The SmileMe Mirror enables the dentist to offer patients a complete Smile Consultation.
REMEDENT, INC. 